Læknablaðið

Ukioqatigiit

Læknablaðið - 15.11.1999, Qupperneq 10

Læknablaðið - 15.11.1999, Qupperneq 10
862 Leghálskrabbameinsleit á Norðurlöndum til 1995 LÆKNABLAÐIÐ 1999; 85 Könnun á nýgengi og dánartíðni, markaldri og bili milli skoðana Kristján Sigurðsson Sigurðsson K The Nordic cervical screening programmes through 1995. Evaluation of incidence and mor- tality rates, targeted age groups and screening intervals Læknablaðið 1999; 85: 862-72 Background: The objective of cervical cancer screening is to lower the incidence and mortality rates of the disease. The Nordic countries have a long experience in cervical cancer screening. Based on this experience this study evaluates the UICC and EC guidelines regarding the effectiveness of organized vs. spontaneous screening, targeted age groups and screening intervals. Material and methods: The study analyses the features of the Icelandic and the Nordic screening programmes and the observed trends in the incidence and mortality rates in these countries through 1995. It also analyses the trends for cytologic preinvasive lesions at first visit and at second and later visits after a normal test(s). The frequency of histologic lesions was calculated for the birth cohort 1920-1926 from the age of 60 and among women referred for colpo- scopic examination in 1994. Results: Organized screening started in all the Nordic countries except Norway soon after 1960. Up to 1985 the target age group and screening interval were most intensive in Iceland. All countries intensi- Frá Leitarstöð Krabbameinsfélagsins. Fyrirspurnir, bréfa- skipti: Kristján Sigurðsson yfirlæknir, Leitarstöð Krabba- meinsfélagsins, pósthólf 5420, 125 Reykjavík. Netfang: kristjan@krabb.is Myndir 1,3, 4, 5 og 6 hafa áður birst í Acta Obstet Gynecol Scand 1999; 78: 478-92 og eru birtar hér með góðfúslegu leyfi blaðsins. Lykilorð: leghálskrabbameinsleit, skipuleg eða sjálfboðuð kembileit, dánartíðni, nýgengi, frumubreytingar, vefjabreyt- ingar, flöguþekjukrabbamein, kirtilkrabbamein. fied the screening intervals after 1985. The reduction in both the mortality and the incidence rates was greatest in Iceland and Finland, intermediate in Sweden and Denmark, and lowest in Norway but in that country organized screening started in 1994. The age-specific incidence in the 20-29 age group has been increasing since 1971 in all the Nordic coun- tries, except in Finland. In Iceland screening has greatly affected the rate of all stages of squamous cell carcinoma, but not the rate of adeno-and adenosquamous carcinomas. The prevalence of preinvasive disease has increased signifícantly since 1980. The rate of moderate to high-grade cytologic changes begins increasing as early as at 20 years of age and moderate to high- grade histologic lesions start to accumulate at 24 to 36 rnonths after a normal smear. The rate of these lesions decreases with the number of negative smears taken. Moderate to high-grade histologic lesions and invasive cancer are practically non-existent after the age of 60 among correctly screened women. A strong correlation is found between increased attendance rates and the proportion of cases diagnosed with a Pap smear at stages IA and IB occult. The latter cases mainly occur among women under the age of 45 and start to appear less than two years after a normal smear. Conclusions: Well-organised screening is more effective than spontaneous screening in reducing the risk of cervical cancer. Screening should preferably start soon after age 20 with a screening interval of two to three years. The screening interval can pro- bably be extended to four years at the age of 50 and screening could stop at the age of 60 to 64 among regularly screened women. Key words: cervical cancer screening, organized screen- ing vs. spontaneous screening strategies, mortality rates, incidence rates, cytologic lesions, histologic lesions, squamous cell carcinoma, adenocarcinoma. Ágrip Markmið: Markmið leghálskrabbameins- leitar er að lækka nýgengi og dánartíðni sjúk-
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.